Back
Cumberland Pharmaceuticals, Inc. 10K Form
Sell
45
CPIX
Cumberland Pharmaceuticals, Inc.
Last Price:
$2.32
Seasonality Move:
6.08%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-10 | 10Q | CPIX/Cumberland Pharmaceuticals, Inc. Quarterly |
| 2023-11-13 | 10Q | CPIX/Cumberland Pharmaceuticals, Inc. Quarterly |
| 2023-08-11 | 10Q | CPIX/Cumberland Pharmaceuticals, Inc. Quarterly |
| 2023-05-12 | 10Q | CPIX/Cumberland Pharmaceuticals, Inc. Quarterly |
| 2022-11-14 | 10Q | CPIX/Cumberland Pharmaceuticals, Inc. Quarterly |
| 2022-08-12 | 10Q | CPIX/Cumberland Pharmaceuticals, Inc. Quarterly |
Receive CPIX News And Ratings
See the #1 stock for the next 7 days that we like better than CPIX
CPIX Financial Statistics
Sales & Book Value
| Annual Sales: | $37.9M |
|---|---|
| Cash Flow: | $155K |
| Price / Cash Flow: | 5.21 |
| Annual Sales: | $1.75 |
| Price / Book: | 1.35 |
Profitability
| EPS (TTM): | -0.23310 |
|---|---|
| Net Income (TTM): | $-3.3M |
| Gross Margin: | $26.4M |
| Return on Equity: | -12.95% |
| Return on Assets: | -4.69% |
Cumberland Pharmaceuticals, Inc. Earnings Forecast
Key Cumberland Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 20 years for CPIX is 69.66%.
-
The Selling, General & Administrative Expenses for CPIX have been equal to 74.34% of Gross Profit Margin.
-
The Research & Development expenses have been 12.72% of Revenue.
-
The Net Earning history of CPIX is -17.02% of Total Revenues.
-
Per Share Earnings over the last 20 years have been positive in 8 years.
Cumberland Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | CPIX |
| CUSIP: | 230770 |
| Website: | cumberlandpharma.com |
Debt
| Debt-to-Equity Ratio: | 0.39 |
|---|---|
| Current Ratio: | 1.23 |
| Quick Ratio: | 1.05 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CPIX Technical Analysis vs Fundamental Analysis
Sell
45
Cumberland Pharmaceuticals, Inc. (CPIX)
is a Sell
Is Cumberland Pharmaceuticals, Inc. a Buy or a Sell?
-
Cumberland Pharmaceuticals, Inc. stock is rated a SellThe current Cumberland Pharmaceuticals, Inc. [CPIX] share price is $2.35. The Score for CPIX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.